New publication in "British Journal of Clinical Pharmacology" on the use of antibiotics during pregnancy and the risk of MCM
19
Jul
In this publication, Flory Tsobo, M.D.,PhD candidate and his colleagues conducted a cohort study using the Quebec Pregnancy Cohort. A large prospective cohort of pregnant women in Quebec. The results of the study show that clindamycin, doxycycline, quinolones, macrolides and phenoxymethylpenicillin in utero exposure were linked to organ-specific malformations. Amoxicillin, cephalosporins and nitrofurantoin were not associated with MCMs. To read the abstract click here.
New publication in Obstetric & Gynecology on Neurodevelopmental outcomes after Assisted Reprocuctive Technologies (ART)
31
Jan
Jacques Balayla, M.D., and his colleagues conducted a study using the prospective cohort 3D-Study. The results of the study show that children born after ART had similar cognitive, motor and language development as children born after natural conception at 2 years of age. Les résultats montrent que les enfants nés suite à des traitements de fertilité ont un développement cognitif, moteur et langagier semblablent à celui des enfants nés de conception naturelle. To read the abstract click here or to see the editor podcast. Media coverage: Physician's Briefing, Fox News Health; babycenter blog.
New publication in BMJ Open
12
Jan
Dr Anick Bérard, PhD and her research team published a new study on the antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women using the Quebec Pregnancy Cohort. Antidepressants with effects on serotonin reuptake during embryogenesis increased the risk of some organ-specific malformations in a cohort of pregnant women with depression. To read more click here. Media coverage: nouvelles umontreal ; medicalresearch; onmedica; emaxhealth.
CIHR funding for the Preterm Birth Network Team
09
Dec
Dr. Anick Bérard is a co-applicant for the "Preterm Birth Network Team Grant", which received a funding of $ 4,250,000 from the Canadian Institutes of Health Research (CIHR) in December 2016. The network also obtained a 10 millions fund guarantee for 2016-2021 from hospitals and research centers.
